Advisors Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-24,748	Closed	-$2.77M	–	421
2021 Q3	$2.77M	Buy	24,748 +1,890	+8%	+$212K	0.08%	184
2021 Q2	$3.7M	Buy	22,858 +1,302	+6%	+$211K	0.12%	158
2021 Q1	$2.63M	Buy	+21,556	New	+$2.63M	0.09%	169